Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea · Delayed Price · Currency is KRW
23,100
0.00 (0.00%)
Aug 8, 2025, 3:30 PM KST
Orum Therapeutics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
TTM | FY 2024 | FY 2023 | FY 2022 |
---|
Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
---|
| 20,893 | 20,906 | 135,418 | 75.92 |
| -84.57% | -84.56% | 178270.49% | - |
| 1.52 | 1.99 | - | 0.83 |
| 20,892 | 20,904 | 135,418 | 75.09 |
| 9,723 | 9,158 | 19,054 | 9,083 |
| 19,173 | 17,043 | 18,706 | 33,168 |
| 157.72 | 170.3 | 280.11 | 182.18 |
| 32,106 | 29,239 | 39,811 | 43,723 |
| -11,215 | -8,335 | 95,607 | -43,648 |
| -1,840 | -1,794 | -824.35 | -75.37 |
Interest & Investment Income | 2,573 | 3,179 | 560.83 | 671 |
Currency Exchange Gain (Loss) | -3,076 | -4,609 | -5,642 | -799.86 |
Other Non Operating Income (Expenses) | 429.53 | 5,445 | -21,199 | -19,197 |
EBT Excluding Unusual Items | -13,129 | -6,114 | 68,502 | -63,050 |
Gain (Loss) on Sale of Investments | 1,343 | 799.27 | -809.55 | -52.63 |
Gain (Loss) on Sale of Assets | - | - | 205.25 | 8.91 |
| -11,786 | -5,315 | 67,898 | -63,093 |
| 425.36 | 424.98 | -319.02 | 225.34 |
| -12,211 | -5,740 | 68,217 | -63,319 |
| -12,211 | -5,740 | 68,217 | -63,319 |
Shares Outstanding (Basic) | 17 | 14 | 5 | 5 |
Shares Outstanding (Diluted) | 17 | 18 | 15 | 5 |
| 15.33% | 20.20% | 227.30% | - |
| -703.14 | -423.62 | 14829.83 | -13764.93 |
| -952.24 | -555.93 | 5646.14 | -13764.93 |
| -13,717 | -12,545 | 93,117 | -41,888 |
| -789.84 | -693.22 | 6184.75 | -9106.02 |
| 99.99% | 99.99% | 100.00% | 98.91% |
| -53.68% | -39.87% | 70.60% | -57492.65% |
| -58.45% | -27.46% | 50.38% | -83402.60% |
| -65.65% | -60.01% | 68.76% | -55173.99% |
| -8,163 | -5,467 | 97,377 | -42,358 |
| -39.07% | -26.15% | 71.91% | - |
| 3,052 | 2,868 | 1,771 | 1,290 |
| -11,215 | -8,335 | 95,607 | -43,648 |
| -53.68% | -39.87% | 70.60% | - |
| - | 4.37 | 3.95 | 10.28 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.